Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
07/2001
07/26/2001CA2398409A1 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
07/26/2001CA2397533A1 Substituted phenylamidines, pharmaceutical compositions containing these compounds and processes for preparation thereof
07/25/2001EP1118612A1 Piperazine derivatives possesing nootropic activity
07/25/2001EP1118610A1 Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
07/25/2001EP1118323A2 Method of reducing morbidity and the risk of mortality
07/25/2001EP1117698A2 Chelates comprising chinoid groups as photoinitiators
07/25/2001EP0889876B1 Meta-substituted phenylene sulphonamide derivatives
07/25/2001CN1305457A Novel antiestrogens, method for production thereof and their pharmaceutical application
07/25/2001CN1305453A Fluorovinyloxyacetamides, process for preparing the same and herbicidal composition comprising the same
07/25/2001CN1305378A Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal fragility
07/25/2001CN1305124A Photo sensitive resin composition
07/25/2001CN1304930A Arylsulfurylisooximino acid derivative
07/24/2001US6265612 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
07/24/2001US6265610 Contrast media for angiography
07/24/2001US6265579 Process for preparing piperazine-substituted aliphatic carboxylates
07/24/2001US6265575 Thrombin inhibitors
07/24/2001US6265458 Photoinitiators and applications therefor
07/24/2001US6265446 Antiinflammatory agents; autoimmune diseases
07/24/2001US6265433 LTA4 hydrolase inhibitors
07/24/2001CA2218503C Arylsulfonyl hydroxamic acid derivatives
07/24/2001CA2191844C Acylated enol derivatives as prodrugs of elastase inhibitors
07/24/2001CA2031588C Substituted cyclohexanols and cyclohexylamines as central nervous system agents
07/19/2001WO2001051474A2 Polypharmacophoric agents
07/19/2001WO2001051469A1 Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists
07/19/2001WO2001051456A2 Antibacterial agents
07/19/2001WO2001051440A1 A process for the preparation of substituted benzophenones
07/19/2001WO2001002345A3 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers
07/19/2001WO2000076970A3 Serine protease inhibitors
07/19/2001US20010008893 Hydroquinone derivatives
07/19/2001CA2397575A1 Antibacterial agents
07/19/2001CA2396007A1 Piperidine and piperazine derivatives
07/18/2001EP1116712A1 Amine derivatives and skin preparations for external use containing the same
07/18/2001EP1116711A2 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds
07/18/2001EP1116486A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
07/18/2001EP1115701A1 Arylsulfonanilide ureas
07/18/2001EP1115697A1 Unsaturated hydroximic acid derivatives as parp inhibitors
07/18/2001EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
07/18/2001EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
07/18/2001EP1034171B1 Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
07/18/2001EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/18/2001EP0690051B1 Diazacycloalkanealkylsulfonamide derivative
07/18/2001EP0636025B1 Compounds useful for treating allergic or inflammatory diseases
07/18/2001CN1304447A Treatment of parasitic diseases by inhibition of cysteine proteases of papain superfamily
07/18/2001CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
07/18/2001CN1068584C Phthalic acid diamide derivatives, agricultural and horicultural insecticides, and method for application of insecticides
07/17/2001US6262112 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
07/17/2001US6262104 Selective delta opioid agonists and antagonists
07/17/2001US6262060 Treatment of hyperglycaemia, diabetes, obesity or inflammation
07/17/2001US6262057 Pseudopolymorphic forms of 2-[2-[4-[Bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
07/12/2001WO2001049681A1 A method for the preparation of substituted benzene derivatives
07/12/2001WO2001049679A1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
07/12/2001WO2001049670A1 5,10-dihydroacridines as calcium channel blockers
07/12/2001WO2001049288A1 Novel compounds and compositions as protease inhibitors
07/12/2001WO2001049275A2 Methods and compositions for mitigating pain using nitrate esters
07/12/2001WO2001021604A8 Substituted piperazine derivatives, the production thereof and their use as inhibitors of the microsomal triglyceride-transfer protein (mtp)
07/12/2001DE19963179A1 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases
07/12/2001DE19945351A1 Verfahren zum Auffinden und zur Isolierung pharmakologisch wirksamer Verbindungen aus Substanzgemischen sowie eine Vorrichtung zur Durchführung des Verfahrens A method for finding and isolating pharmacologically active compounds from substance mixtures, and an apparatus for carrying out the method
07/12/2001DE10000739A1 New piperidine and piperazine derivatives which are antagonists of certain serotonin receptors, are useful in treatment of, e.g. eating disorders, stroke, anxiety or Parkinson's disease
07/12/2001CA2475413A1 Compositions and methods for treating conditions responsive to estrogen
07/12/2001CA2475393A1 Compositions and methods for treating conditions responsive to estrogen
07/12/2001CA2396257A1 Novel compounds and compositions as protease inhibitors
07/12/2001CA2394199A1 5,10-dihydroacridines as calcium channel blockers
07/12/2001CA2394184A1 Methods and compositions for mitigating pain using nitrate esters
07/12/2001CA2331059A1 Method of reducing morbidity and the risk of mortality
07/11/2001EP1114819A1 Process to prepare oxazolidinones
07/11/2001EP1114034A1 Method for the joint production of a cyclic lactam and a cyclic amine
07/11/2001EP1114026A1 Method for simultaneously producing a cyclic lactam and a cyclic amine
07/11/2001EP1114024A1 Urokinase inhibitors
07/11/2001EP0823896B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
07/11/2001CN1303381A Dipeptidyl peptidase IV effectors
07/11/2001CN1303376A Compound with activity on muscarinic receptors
07/11/2001CN1303365A Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
07/11/2001CN1303364A Aminocyclohexyl ether compounds and uses thereof
07/11/2001CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity
07/11/2001CN1068324C Crystalline substituted benzothiophene hydrochlorate, pharmaceutical preparation and its use
07/10/2001US6258953 Arylacrylamide derivatives
07/10/2001US6258838 Compounds
07/10/2001US6258833 Enzyme inhibitors and antiinflammatory agents
07/10/2001US6258822 Urokinase inhibitors
07/10/2001US6258813 D4 receptor selectivity piperazine derivatives
07/10/2001US6258775 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
07/10/2001CA2175643C Utilization of retinoids in a cosmetic composition or in the preparation of a pharmaceutical composition
07/05/2001WO2001047905A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
07/05/2001WO2001047899A1 Substituted piperazine derivatives as mtp inhibitors
07/05/2001WO2001047898A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
07/05/2001WO2001047875A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
07/05/2001WO2001047868A1 Novel phenylalanine derivatives
07/05/2001WO2001047866A1 Substituted 1 and 2 naphthol mannich bases
07/05/2001WO2001047859A1 Compounds active at the glucocorticoid receptor
07/05/2001WO2001047836A1 Novel selective deacetylating agents
07/05/2001WO2000073278A3 5-phenyl-pyrimidine derivatives
07/05/2001WO2000050376A3 Efficient synthesis of alkyl carbonates
07/05/2001US20010006619 Compounds for cancer imaging and therapy
07/05/2001DE19963235A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments
07/05/2001CA2395716A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
07/05/2001CA2395249A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments
07/05/2001CA2394644A1 Substituted piperazine derivatives,the preparation thereof and their useas medicaments
07/05/2001CA2394098A1 Substituted 1 and 2 naphthol mannich bases
07/05/2001CA2393583A1 Compounds active at the glucocorticoid receptor
07/04/2001EP1112288A1 Thermal- and photoinitiated radical polymerization in the presence of an addition fragmentation agent